Table 1.
Saskatoon, Canada n = 72 | Mexico City, México n = 76 | p | |
---|---|---|---|
Age (± SD) | 36.7 (± 13.2) | 37.4 (± 9.03) | 0.70 |
Sex (%) | |||
Male | 38 (53%) | 34 (49%) | 0.41 |
Female | 34 (47%) | 42 (51%) | |
Years of evolution of epilepsy mean (± SD) | 20.2 (± 13.6) | 27.38 ± 10 | 0.0004 |
Epileptic syndromes (%) | |||
Structural‐metabolic | 57 (80%) | 73 (96%) | 0.006 |
Unknown | 14 (19%) | 3 (4%) | |
Genetic | 1 (1%) | 0 (0%) | |
VEEG localization | |||
Right | 31 (43%) | 37 (49%) | 0.0007 |
Left | 37 (51%) | 22 (29%) | |
No clear localization | 0 | 11 (14%) | |
Multifocal | 2 (3%) | 6 (8%) | |
Generalized | 2 (3%) | 0 | |
MRI findings | |||
MTS | 35 (48%) | 59 (78%) | <0.001 |
Cortical dysplasia | 3 (4%) | 6 (8%) | |
Stroke | 2 (3%) | 4 (5%) | |
Cyst | 0 | 2 (3%) | |
Cerebral neoplasm | 4 (6%) | 0 (0%) | |
AVM | 1 (1%) | 0 (0%) | |
Normal | 20 (28%) | 0 (0%) | |
Encephalomalacia | 7 (10%) | 1 (1%) | |
Others | 0 | 2 (3%) | |
Not done | 0 | 1 (1%) | |
Seizures per month (group) | |||
1 to 3 | 37 (51%) | 14 (18%) | 0.0001 |
4 to 6 | 11 (15%) | 15 (20%) | |
7 or more | 24 (33%) | 47 (62%) | |
Number of AEDs (group) | |||
0 | 0 | 2 (3%) | 0.06 |
1 | 8 (11%) | 3 (4%) | |
2 | 33 (46%) | 31 (41%) | |
3 | 25 (35%) | 28 (37%) | |
4 or more | 6 (8%) | 12 (15%) | |
Type of epilepsy surgery | |||
Standard temporal lobectomy | 54 (75%) | 46 (61%) | 0.0004 |
Selective hippocampectomy | 3 (4%) | 19 (25%) | |
Extratemporal resection | 6 (8%) | 0 (0%) | |
Lesionectomy | 2 (3%) | 5 (6%) | |
Callosotomy | 3 (4%) | 6 (8%) | |
Frontotemporal resection | 3 (4%) | 0 | |
VNS | 1 (1%) | 0 | |
Engel classification at last follow‐up Engel | |||
I | 50 (69%) | 54 (71%) | 0.06 |
II | 12 (17%) | 6 (8%) | |
III | 5 (7%) | 6 (8%) | |
IV | 5 (7%) | 10 (13%) |
Data are presented % = percentage; AED, antiepileptic drugs; AVM, arteriovenous malformation; MRI, magnetic resonance imaging; MTS, mesial temporal sclerosis; SD, standard deviation; VEED, video electroencephalography; VNS, vagus nerve estimulation.